Novartis Partnership

HL Pharma is pleased to announce it is partnering with Novartis Australia to supply one of their ophthalmic products under The Special Access Scheme or Authorised Prescriber Scheme. This is until the Australian registered product becomes available.  

Glanatec (ripasudil) 0.4% Eye Drops

Glanatec (ripasudil) 0.4% Eye Drops Ripasudil is a Rho Kinase inhibitor, licensed in Japan. This product is not registered in Australia and is available for supply under The Special Access Scheme (SAS) C

Phenelzine 15mg Tablets

Phenelzine (Nardil) 15mg Tablets have been discounted in Australia. Phenelzine is still available from overseas. HL Pharma can arrange supply of Phenelzine 15mg Tablets from overseas under various TGA approved processes. If you are a patient, please ask your pharmacist to get in touch with us as we are only [...]